Palifermin 5.16 MG Injection — RxCUI 2643434
RxNorm drug concept · Semantic clinical drug
RxCUI 2643434
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
1 package NDC
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI2643434
Official namePalifermin 5.16 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Palifermin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Kepivance is given to help protect the lining of your mouth and throat during the intense chemotherapy or radiation you receive before your stem cell transplant. That treatment can...
- What exactly is Kepivance for, and why am I getting it?
- Kepivance is given as a quick IV injection by your care team — not as a pill you take at home. You'll receive it once a day for 3 days before your chemotherapy starts, and then onc...
- The most common side effects are skin-related: rash, redness, itching, and swelling. You may also notice a thickened or discolored feeling in your mouth or on your tongue, a change...
🕸️ Concept Web — How Palifermin 5.16 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Palifermin 5.16 MG Injection
RxCUI 2643434 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Palifermin
196319IN
-
Palifermin
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Kepivance
545354BN
-
Kepivance
-
Dose forms 6
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Palifermin Injection
1737725SCDF -
Palifermin Injectable Product
1163534SCDG -
Palifermin Injection [Kepivance]
1737727SBDF -
Kepivance Injectable Product
1170051SBDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Palifermin Injection
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Palifermin 5.16 MG
2643433SCDC -
Palifermin 5.16 MG Injection [Kepivance]
2643436SBD -
Palifermin 5.16 MG [Kepivance]
2643435SBDC
-
Palifermin 5.16 MG
Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Palifermin 5.16 MG
SCDC · 2643433 -
Palifermin Injection
SCDF · 1737725 -
Palifermin Injectable Product
SCDG · 1163534
Brand-Name Concepts
-
Palifermin 5.16 MG Injection [Kepivance]
SBD · 2643436 -
Palifermin 5.16 MG [Kepivance]
SBDC · 2643435 -
Palifermin Injection [Kepivance]
SBDF · 1737727 -
Kepivance Injectable Product
SBDG · 1170051 -
Kepivance
BN · 545354
📦 FDA Products & Package NDCs
1 product · 1 package NDC
1 package NDC map to RxCUI 2643434 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 66658-0113-03 | 3 VIAL, SINGLE-USE in 1 CARTON (66658-113-03) / 1.2 mL in 1... | KEPIVANCE | Swedish Orphan Biovitrum AB (publ) | 2023-08-04 |
Observed labelers:
Swedish Orphan Biovitrum AB (publ) (1)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J2425 | Palifermin injection | 1 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.